Orchestra BioMed Holdings, Inc.OBIONASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+192.9%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+192.9%/yr
Quarterly compound
Percentile
P100
Near historical high
vs 3Y Ago
25.1x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 129.98% |
| Q3 2025 | -7.57% |
| Q2 2025 | -3.24% |
| Q1 2025 | -16.09% |
| Q4 2024 | -4.73% |
| Q3 2024 | 3.47% |
| Q2 2024 | -18.70% |
| Q1 2024 | -5.03% |
| Q4 2023 | 3.74% |
| Q3 2023 | -10.54% |
| Q2 2023 | -10.11% |
| Q1 2023 | -12.21% |
| Q4 2022 | 5.17% |
| Q3 2022 | -31.03% |
| Q2 2022 | -36.97% |
| Q1 2022 | 28.96% |
| Q4 2021 | -53.41% |
| Q3 2021 | 14.59% |
| Q2 2021 | -74.02% |
| Q1 2021 | 0.00% |